glp-1 news november 2025 supply shortage ISPOR 2025: Exploring reasons for discontinuation GLP-1 Drugs Driving Protein Demand – GLP-1 Receptor Agonists and vision

IGF-1 LR3 is engineered with an N-terminal extension and Arg3 substitution that reduces IGFBP-3 binding, extending its effective activity substantially longer in preclinical models

Conversely, RBA-NPs, an innovative pH-responsive dual-target drug delivery system designed to target both CD44 and folate receptors, effectively downregulates macrophage glycolysis by inhibiting the ERK/HIF-1/GLUT1 signaling axis

See: Perinatal Services BC (PSBC) www.perinatalservicesbc.ca Perinatal Services BC (PSBC) provides leadership, support, and coordination for the strategic planning of perinatal services in British Columbia and is the central source in the province for evidence-based perinatal information

Regular monitoring ensures optimal dosing, safety, and visible results in skin clarity, energy, and overall wellness